CELLACT Pharma GmbH
Notifications

CellAct ASCO 3.6 2016: CellAct Pharma Phase 2 CAP7.1 Population Pharmacokinetic Data Supports Efficacy Results in Biliary Tract Cancers


CellAct ASCO 2016.pdf (97kb):




CellAct Pharma Presents Interim Phase 2 Data Showing CAP7.1 Initial Efficacy in Biliary Tract Cancers at ASCO GI


ASCO GI 25.1.16.pdf (99kb):




CellAct Pharma Presents Interim Phase 2 Data Showing CAP7.1 Initial Efficacy in Biliary Tract Cancers at ASCO GI


ASCO GI 25.1.16.pdf (99kb):




CellAct reports on Phase I study on CAP7.1 at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland (09.11.2012)


Open/Download PDF (315kb):




CellAct Advances Phase 1 Clinical Trial Release (16-10-09)


Open/Download PDF (315kb):




About CellAct Pharma in Going Public Journal 2008


Open/Download PDF (644kb):




COMPANY | RESEARCH & DEVELOPMENT | PARTNERS | NEWS | CONTACT